RECRUITING

Characterization and Treatment of Adolescent Depression

Conditions

Depression Cognitive Behavior Therapy Mood Disorder Biomarkers Mechanism Major Depressive Disorder (MDD)Natural History

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study seeks to find causes and treatments of depression in teenagers. The study goals are to increase our knowledge of treatments for depression and understand how the brain changes when teenagers have depression. The study will also compare teenagers with depression to those without mental health diagnoses. This outpatient study is recruiting participants ages 11-17 who are depressed. They must have a pediatrician or other medical provider, be medically healthy, and able to perform research tasks. They may not currently be hospitalized, psychotic or actively suicidal. Teenagers with depression are eligible even if they are taking medication. The study begins with an evaluation that includes clinical assessment, interviews, and questionnaires. * Visits may include paper-and-pencil and computer tests of mood, memory, and thinking; specialized computer games; and structural and brain imaging. If eligible, study participants may return several times a year for up to two years. This part of the study does not involve treatment. * Participants may be eligible for outpatient treatment for up to 25 weeks. This includes evidenced-based "talk" therapy. Participants may choose either Interpersonal Psychotherapy for Adolescents (IPT-A) or Cognitive Behavioral Therapy (CBT). If indicated, participants may opt to receive standard medication treatments along with psychotherapy. Research includes computer tasks and brain imaging. All clinical evaluations, research tasks and visits are free of cost. Participants are compensated for research activities. Parents and teenager must agree to the teenager s participation in research. The study is conducted at the NIH in Bethesda, Maryland and enrolls participants from the Washington DC Metro region within 50 miles of NIH. Transportation expenses are reimbursed by NIMH....

Official Title

Characterization and Treatment of Adolescent Depression

Quick Facts

Study Start:2017-12-28

Study Completion:2026-07-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT03388606

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:11 Years to 25 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD, ADULT

Inclusion Criteria	Exclusion Criteria
* Youths who meet DSM 5 criteria for Major Depressive Disorder (Group 1) * Ages 11-17 at the time of enrollment in Characterization; * Current diagnosis of DSM-5 Major Depressive Disorder (within the last six months from assessment) which are: * Five or more of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. * Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feeling sad, blue, "down in the dumps,"or empty) or observation made by others (e.g., appears tearful or about to cry). (In children and adolescents, this may present as an irritable or cranky, rather than sad, mood.) * Markedly diminished interest or pleasure in all, or almost all, activities every day, such as no interest in hobbies, sports, or other things the person used to enjoy doing. * Significant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body weight in a month) or decrease or increase in appetite nearly every day. * Insomnia (inability to get to sleep or difficulty staying asleep) or hypersomnia (sleeping too much) nearly every day * Psychomotor agitation (e.g., restlessness, inability to sit still, pacing, pulling at clothes or clothes) or retardation (e.g., slowed speech, movements, quiet talking) nearly every day * Fatigue, tiredness, or loss of energy nearly every day (e.g., even the smallest tasks, like dressing or washing, seem difficult to do and take longer than usual). * Feelings of worthlessness or excessive or inappropriate guilt nearly every day (e.g., ruminating over minor past failings). * Diminished ability to think or concentrate, or indecisiveness, nearly every day (e.g., appears easily distracted, complains of memory difficulties). * Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideas without a specific plan, or a suicide attempt or a specific plan for committing suicide * Symptoms cause clinically significant distress or impairment in social, occupational/academic, or other important areas of functioning. * The episode is not attributable to the physiological effects of a substance or to another medical condition. * Inclusion criteria for subthreshold depressive disorder were: * Ages 11-17 at the time of enrollment in Characterization; * An episode of depressed mood or loss of interest or pleasure lasting at least 1 week plus * At least two of the seven other DSM-5-associated symptoms for major depression * Occurring in the last six months. * Adolescent Healthy Volunteers (Group 3a) * Youth 11 to 17 years of age at time of enrollment in Characterization * the adolescent must be competent to assent; parents must be able comprehend and provide permission for their child (consent). * Participants will be willing to participate in NIMH IRB approved research protocols. Minors will be asked to sign assent forms and their parents will sign the consent form. * Participants will be willing to undergo an evaluation, which may include a psychiatric interview, review of medical history (including Tanner staging for minors), and pregnancy testing. * Speaks English. * Have an identified primary care clinician. * Adult Healthy Volunteers (Group 3b) * Adults 18 to 30 years of age at time of enrollment in Characterization * Subjects must be competent to consent. * Participants will be willing to participate in NIMH IRB approved research protocols. * Participants will be willing to undergo an evaluation, which may include a psychiatric interview, review of medical history, and pregnancy testing (for females). * Speaks English. * Has an identified primary care clinician. * Are the biological parent or legal guardian of an enrolled adolescent (who is a healthy volunteer or has MDD) participant; Parents of those with s-MDD are historical only; none enrolled after Dec 2021. * Those of all ages are eligible if they are a parent of a currently enrolled participant	* Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, bipolar disorder, more than mild Autism Spectrum Disorder, current Anorexia Nervosa or other severe Eating Disorder. * Intellectual disability (clinically identified or IQ \< 70) * For subjects with major depression or sub-threshold major depressive episode: Symptoms of depression are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition by self and parent report. * Meets DSM-5 criteria for alcohol or substance use disorder (excluding tobacco and nicotine use) within the last three months. This is determined solely by clinical interview of child and parent (e.g., KSADS). * Current active suicidal ideation (i.e., presence of intent for engaging in suicidal behaviors). * Participants with repeated self-harm occurring in the context of inter-personal conflict. * Intellectual disability (clinically identified or IQ \< 70). * Any serious medical condition (such as epilepsy, heart disease requiring medication) by self and parent report. * Past or current diagnosis of a manic or hypomanic episode, major depression), schizophrenia, schizophreniform disorder, schizoaffective illness, Tourette Disorder, or Autism Spectrum Disorder, Anorexia Nervosa or other severe Eating Disorder. * Meets DSM-5 criteria for alcohol or substance abuse within the last three months by self and parent report. * NIMH IRP Employees/staff and immediate family members will be excluded from the study per NIMH policy.

Inclusion Criteria

Exclusion Criteria

* Youths who meet DSM 5 criteria for Major Depressive Disorder (Group 1)
* Ages 11-17 at the time of enrollment in Characterization;
* Current diagnosis of DSM-5 Major Depressive Disorder (within the last six months from assessment) which are:
* Five or more of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure.
* Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feeling sad, blue, "down in the dumps,"or empty) or observation made by others (e.g., appears tearful or about to cry). (In children and adolescents, this may present as an irritable or cranky, rather than sad, mood.)
* Markedly diminished interest or pleasure in all, or almost all, activities every day, such as no interest in hobbies, sports, or other things the person used to enjoy doing.
* Significant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body weight in a month) or decrease or increase in appetite nearly every day.
* Insomnia (inability to get to sleep or difficulty staying asleep) or hypersomnia (sleeping too much) nearly every day
* Psychomotor agitation (e.g., restlessness, inability to sit still, pacing, pulling at clothes or clothes) or retardation (e.g., slowed speech, movements, quiet talking) nearly every day
* Fatigue, tiredness, or loss of energy nearly every day (e.g., even the smallest tasks, like dressing or washing, seem difficult to do and take longer than usual).
* Feelings of worthlessness or excessive or inappropriate guilt nearly every day (e.g., ruminating over minor past failings).
* Diminished ability to think or concentrate, or indecisiveness, nearly every day (e.g., appears easily distracted, complains of memory difficulties).
* Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideas without a specific plan, or a suicide attempt or a specific plan for committing suicide
* Symptoms cause clinically significant distress or impairment in social, occupational/academic, or other important areas of functioning.
* The episode is not attributable to the physiological effects of a substance or to another medical condition.
* Inclusion criteria for subthreshold depressive disorder were:
* Ages 11-17 at the time of enrollment in Characterization;
* An episode of depressed mood or loss of interest or pleasure lasting at least 1 week plus
* At least two of the seven other DSM-5-associated symptoms for major depression
* Occurring in the last six months.
* Adolescent Healthy Volunteers (Group 3a)
* Youth 11 to 17 years of age at time of enrollment in Characterization
* the adolescent must be competent to assent; parents must be able comprehend and provide permission for their child (consent).
* Participants will be willing to participate in NIMH IRB approved research protocols. Minors will be asked to sign assent forms and their parents will sign the consent form.
* Participants will be willing to undergo an evaluation, which may include a psychiatric interview, review of medical history (including Tanner staging for minors), and pregnancy testing.
* Speaks English.
* Have an identified primary care clinician.
* Adult Healthy Volunteers (Group 3b)
* Adults 18 to 30 years of age at time of enrollment in Characterization
* Subjects must be competent to consent.
* Participants will be willing to participate in NIMH IRB approved research protocols.
* Participants will be willing to undergo an evaluation, which may include a psychiatric interview, review of medical history, and pregnancy testing (for females).
* Speaks English.
* Has an identified primary care clinician.
* Are the biological parent or legal guardian of an enrolled adolescent (who is a healthy volunteer or has MDD) participant; Parents of those with s-MDD are historical only; none enrolled after Dec 2021.
* Those of all ages are eligible if they are a parent of a currently enrolled participant

* Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, bipolar disorder, more than mild Autism Spectrum Disorder, current Anorexia Nervosa or other severe Eating Disorder.
* Intellectual disability (clinically identified or IQ \< 70)
* For subjects with major depression or sub-threshold major depressive episode: Symptoms of depression are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition by self and parent report.
* Meets DSM-5 criteria for alcohol or substance use disorder (excluding tobacco and nicotine use) within the last three months. This is determined solely by clinical interview of child and parent (e.g., KSADS).
* Current active suicidal ideation (i.e., presence of intent for engaging in suicidal behaviors).
* Participants with repeated self-harm occurring in the context of inter-personal conflict.
* Intellectual disability (clinically identified or IQ \< 70).
* Any serious medical condition (such as epilepsy, heart disease requiring medication) by self and parent report.
* Past or current diagnosis of a manic or hypomanic episode, major depression), schizophrenia, schizophreniform disorder, schizoaffective illness, Tourette Disorder, or Autism Spectrum Disorder, Anorexia Nervosa or other severe Eating Disorder.
* Meets DSM-5 criteria for alcohol or substance abuse within the last three months by self and parent report.
* NIMH IRP Employees/staff and immediate family members will be excluded from the study per NIMH policy.

Contacts and Locations

Study Contact

Daniel S Pine, M.D.

CONTACT

(301) 594-1318

daniel.pine@nih.gov

Principal Investigator

Daniel S Pine, M.D.

PRINCIPAL_INVESTIGATOR

National Institute of Mental Health (NIMH)

Study Locations (Sites)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892

United States

Collaborators and Investigators

Sponsor: National Institute of Mental Health (NIMH)

Daniel S Pine, M.D., PRINCIPAL_INVESTIGATOR, National Institute of Mental Health (NIMH)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-12-28

Study Completion Date2026-07-01

Study Record Updates

Study Start Date2017-12-28

Study Completion Date2026-07-01

Terms related to this study

Keywords Provided by Researchers

Cognitive Behavior Therapy
Mood Disorder
Biomarkers
Mechanism
Major Depressive Disorder (MDD)
Natural History

Additional Relevant MeSH Terms

Depression